Related references
Note: Only part of the references are listed.High Cell-Free DNA Integrity Is Associated with Poor Breast Cancer Survival
Maria Lamminaho et al.
CANCERS (2021)
Combining 18F-FDG PET/CT-Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer
Erwin Woff et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Enrichment of shortmutant cell-free DNA fragments enhanced detection of pancreatic cancer
Xiaoyu Liu et al.
EBIOMEDICINE (2019)
Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy
J. Hamfjord et al.
ANNALS OF ONCOLOGY (2019)
Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study
Dominic G. Rothwell et al.
NATURE MEDICINE (2019)
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
Thomas Reinert et al.
JAMA ONCOLOGY (2019)
Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patients
Ida Viller Tuxen et al.
BRITISH JOURNAL OF CANCER (2019)
Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma
Theodora Kanaki et al.
EUROPEAN JOURNAL OF CANCER (2019)
Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial
Marianna Alunni-Fabbroni et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA
Ymke van der Pol et al.
CANCER CELL (2019)
Monitoring Tumor Burden in Response to FOLFIRINOX Chemotherapy Via Profiling Circulating Cell-Free DNA in Pancreatic Cancer
Tao Wei et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Diagnostic Value of Concentration of Circulating Cell-Free DNA in Breast Cancer: A Meta-Analysis
Dandan Yu et al.
FRONTIERS IN ONCOLOGY (2019)
Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond
Jeffrey E. Gershenwald et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
The value of fluorimetry (Qubit) and spectrophotometry (NanoDrop) in the quantification of cell-free DNA (cfDNA) in malignant melanoma and prostate cancer patients
Giovanni Ponti et al.
CLINICA CHIMICA ACTA (2018)
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
Sarah B. Goldberg et al.
CLINICAL CANCER RESEARCH (2018)
Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients
S. Valpione et al.
EUROPEAN JOURNAL OF CANCER (2018)
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
Seung Tae Kim et al.
NATURE MEDICINE (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Circulating cell free DNA as the diagnostic marker for colorectal cancer: a systematic review and meta-analysis
Xin Wang et al.
Oncotarget (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Prognostic value of circulating cell-free DNA in patients with pancreatic cancer: A systemic review and meta-analysis
Linyan Chen et al.
GENE (2018)
Integrating liquid biopsies into the management of cancer
Giulia Siravegna et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Quantification of circulating cell-free DNA to predict patient survival in non-small-cell lung cancer
Myung Han Hyun et al.
ONCOTARGET (2017)
Circulating free DNA concentration is an independent prognostic biomarker in lung cancer
Claire Tissot et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
S3-Leitlinie ,,Diagnostik, Therapie und Nachsorge des Melanoms” - Kurzfassung
Annette Pflugfelder et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2013)
Multiparametric Analysis of Cell-Free DNA in Melanoma Patients
Francesca Salvianti et al.
PLOS ONE (2012)
Circulating nucleic acids (CNAs) and cancer - A survey
M. Fleischhacker et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2007)
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
